Delivery Order SPE2DR25D2012-SPE2DR26F1BQL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of dextroamphetamine-amphetamine 20 mg capsules (100-count units) under a firm fixed-price contract valued at $1,105.18. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 22, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,947.60 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.06 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg capsules (100 count) on December 16, 2025, with completion due by December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal pharmaceutical supply agreements. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,110.24 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on December 19, 2025, with completion scheduled for December 22, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded to the contractor. The pharmaceutical supply will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,131.09. This is a firm fixed price delivery order with no set-aside designation, issued competitively. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,751.28 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 30 mg capsules (100 count) on December 10, 2025, with completion scheduled for December 11, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,028.08 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on December 22, 2025, with completion scheduled for December 23, 2025. This delivery order was competitively awarded without set-aside designation and utilizes firm fixed pricing. The pharmaceutical product will be delivered to the awardee's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,498.56 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on November 5, 2025, with completion scheduled for November 6, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, representing a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,460.67. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a contract ceiling value of $1,594.31. This firm fixed-price delivery order, which is set to be completed by December 19, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis and represents a child contract under...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BQLDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,156.08 delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 20 mg capsules (100 count) with a firm fixed price contract type. This delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 30, 2025. The award was issued on December 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The delivery order for this controlled substance medication supports DLA's Medical Supply Chain operations and demonstrates the company's capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains through open competitive contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/28/25 |